“…Researchers should obtain an adequate informed consent from donors to respect their autonomy (12,20,22,27,28,34,38,43,45,52,57,63,67,(72)(73)(74)(75)(76), and give them some degree of insight and perhaps control over the use of donated materials by informing them about the types of incidental findings they wish to receive, future commercial applications, individualized research and therapeutic uses (12,20,27,38,43,52,72,76), for instance by maintaining an ongoing dialogue with the donors (76). Moreover, to safeguard the health of the recipient over the years, it may be necessary to periodically obtain records on the medical and family history of the cell donor to monitor potential health risks, such as long-term immunological or tumorigenic reactions (12,19,20,22,27,28,32,34,35,39,41,49,(51)(52)(53).…”